Published by:


Stock News Now

EDISON, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it will present at The 2017 Marcum MicroCap Conference being held June 15-16, 2017, at the Grand Hyatt New York in New York City.James Sapirstein, Chief Executive Officer of ContraVir, will provide an overview of the Company's business during his live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend...

QR Code
Embed the QR code on your website:
Download
Copy